News

12/12/2018

The José Carreras Foundation promotes the first clinical trial in Europe of CAR-T immunotherapy for T lymphomas and Hodgkin’s lymphoma at the Hospital de Sant Pau

The José Carreras Leukaemia Foundation and the Hospital de Sant Pau presented today at a press conference the campaign "The factory of unstoppable cells", a clinical trial of immunotherapy CAR-T to o...

05/12/2018

Dr. Gordon Guyatt’s Seminar at Sant Pau Hospital

The Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, in collaboration with the Epidemiology Service and the Dr. Antoni Esteve Foundation, organized the seminar "Past, Present and Future ...

05/12/2018

Interview Valles Visio: Nanoligent

In June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...

30/11/2018

Sant Pau researchers agree to alleviate diabetic neuropatiia

Researchers at the Institut de Recerca de Sant Pau, the Institut de Neurociències de la Universitat Autònoma de Barcelona and the CIBER de Diabetis i Malalties Metabòliques Associades (CIBERDEM) ha...

29/11/2018

Inflammation and Vascular Reshaping Research Group Publishes in Scientific Reports

The Research Group on Inflammation and vascular remodelling of the IIB Sant Pau, led by Dr. Cristina Rodríguez, has recently published the article "Lysyl oxidase (LOX) limits VSMC proliferation and n...